Trade Dana Gas PJSC - DANA
Dana Gas PJSC (ADX: DANA) is one of the Middle East’s largest independent natural gas companies, playing a vital role in the region’s energy sector. Specialising in exploration, production, and processing, the company supplies clean and efficient natural gas to support economic and industrial growth across key markets. With operations spanning the UAE, Egypt, and the Kurdistan Region of Iraq, Dana Gas focuses on sustainable energy solutions, leveraging advanced technologies to optimise production and efficiency. Its commitment to responsible energy development ensures environmental sustainability while meeting the growing demand for natural gas. Driven by innovation and strategic expansion, Dana Gas continues to strengthen its position as a key contributor to the region’s energy security and long-term economic development.Latest shares articles

BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago

Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
15 hours ago

CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
16 hours ago

Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
19 hours ago